Labshake search
Citations for R&D Systems :
901 - 950 of 2868 citations for Primary Human Cardiac Fibroblast Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... with the exception of human epidermal growth factor (R&D Systems), bovine pituitary extract (Gibco ...
-
bioRxiv - Cancer Biology 2024Quote: The Proteome Profiler Human XL Cytokine Array Kit (R&D Systems) was used to measure the secretion of 105 different soluble factors and cytokines in GBM tumor conditioned media ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml recombinant human VEGF 165 protein (R&D Systems), 10 ng/ml human bFGF (Invitrogen) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL recombinant human VEGF 165 Protein (R&D Systems) and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... the primary antibody (1:1000, stock 0.5 µg/µl, R&D systems, AF3690) was incubated overnight at 4°C ...
-
bioRxiv - Neuroscience 2022Quote: Primary antibodies used for immunofluorescence were PDGFRα (1:200, R&D Systems, AF1062), Olig2 (1:200 ...
-
Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative diseasebioRxiv - Neuroscience 2021Quote: ... Sections were then incubated with primary antibodies for progranulin (AF2420 R&D Systems) and NeuN (MAB377 MilliporeSigma ...
-
bioRxiv - Molecular Biology 2019Quote: ... The following primary antibodies were used: OCT4 (R&D Systems AF1759; 1:250), SSEA-4 (SCBT SC21704 ...
-
bioRxiv - Bioengineering 2021Quote: ... Cerebrum primary antibody solution contained mouse anti-GFAP IgG (R&D Systems, MAB2594) and DAPI to visualize astrocytes and cell nucleus respectively ...
-
bioRxiv - Microbiology 2021Quote: Primary antibodies used for immunoblotting: pan-ACE2 (1:1000; R&D Systems; AF933), hACE2 (1:1000 ...
-
bioRxiv - Microbiology 2021Quote: ... Primary staining for ACE2 (goat anti-ACE2, AF933, R&D systems, 4μg/mL) was performed first ...
-
bioRxiv - Neuroscience 2021Quote: ... the sections were incubated for ON in primary antibody (SOX2, R&D Systems, MAB2018 ...
-
bioRxiv - Cell Biology 2020Quote: ... primary myoblasts were treated with either 200mM SAG (Smoothened agonist, R&D Systems) or 25μM FSK (Forskolin ...
-
bioRxiv - Immunology 2020Quote: Primary antibodies included: 1:200 goat anti-GFRα2 (R&D Systems, Minneapolis, MI), 1:200-1:400 rabbit anti-PGP9.5 (Thermo ...
-
bioRxiv - Neuroscience 2021Quote: ... with diluted primary antibodies: anti-CD31 (R&D Systems, clone AF3628, 1:400), anti-Lyve-1(ReliaTech GmbH ...
-
bioRxiv - Neuroscience 2022Quote: ... with two primary antibodies: goat anti-NANOG (1:200, #AF1997, R&D Systems) and mouse anti-TRA-1-60 (1:200 ...
-
bioRxiv - Biochemistry 2019Quote: ... followed by staining for ESM1 (primary goat anti-ESM1 antibody; R&D Systems). After mounting ...
-
bioRxiv - Neuroscience 2021Quote: ... Primary antibodies used were goat anti-ACE2 (R&D systems, AF933, 1:200), mouse anti-NG2 (Abcam ...
-
bioRxiv - Developmental Biology 2019Quote: ... and incubated with the target recognizing primary antibodies (Kim1, goat, R&D Systems, AF1817 ...
-
bioRxiv - Genomics 2021Quote: ... Primary antibodies against the following TFs were used: GATA6 (R&D Systems, AF1700), NANOG (Active Motif ...
-
bioRxiv - Cancer Biology 2020Quote: ... We used the following primary antibodies: ALCAM (R&D Systems; 1/40 dilution), RPS14 (Invitrogen ...
-
bioRxiv - Developmental Biology 2021Quote: ... The primary antibodies were: sheep anti-NEUROG3 (1:1000, AF3444, R&D Systems), chicken anti-GFP (1:1000 ...
-
bioRxiv - Developmental Biology 2020Quote: ... Primary antibodies Nkx6.1 (1:100, DSHB) and Pdx1 (1:100, R&D Systems) were added and incubated for 30 minutes ...
-
bioRxiv - Cancer Biology 2022Quote: ... Double immunofluorescence staining was performed with primary antibodies anti-ITGB2 (R&D Systems), anti-ITGB6 (R&D Systems) ...
-
bioRxiv - Cell Biology 2022Quote: ... The primary antibody was monoclonal anti-β1-integrin (AF 2325; R&D Systems) at the dilution of 1:10 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and incubated with a primary antibody against myosin heavy chain (R&D Systems) overnight at 4°C with gentle agitation ...
-
bioRxiv - Developmental Biology 2023Quote: ... Primary antibodies were goat anti-SHH (AF464, 0.1 μg/mL; R&D Systems); rat anti-keratin 8 (TROMA-1 ...
-
bioRxiv - Genetics 2023Quote: ... Primary antibodies used in this study were KLF4 (AF3158) from R&D Systems, GAPDH (V-18 ...
-
bioRxiv - Neuroscience 2024Quote: ... Primary antibodies were goat anti SHH-Nter (1:100, R&D system AF464), goat anti Netrin G1a (NG1a ...
-
bioRxiv - Microbiology 2023Quote: ... The following primary antibodies were used: anti-90K/LGALS3BP (#AF2226: R&D Systems), anti-BST2/Tetherin (#390719 ...
-
bioRxiv - Neuroscience 2024Quote: ... The primary antibodies were goat anti-Sema7A (1:200; AF1835, R&D Systems) (Figure 1—figure supplement 4 ...
-
bioRxiv - Microbiology 2020Quote: ... were incubated with activated human recombinant CatL (R&D systems, Minneapolis, MN) at 2 ng/µl or THL (Sigma-Aldrich ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... or 200 ng/ml recombinant human IGF2 (292-G2, R&D Systems) for 24 hours before measuring cell viability ...
-
bioRxiv - Cancer Biology 2021Quote: ... c-Met signalling was stimulated with recombinant human HGF (R&D Systems) at a final concentration of 75 nM ...
-
bioRxiv - Cell Biology 2020Quote: ... 100 ng/ml Recombinant Human/Mouse/Rat Activin A (R&D Systems) and 3μM CHIR99021 (Stemgent) ...
-
bioRxiv - Cell Biology 2020Quote: ... PE anti-human ULBP-2/5/6 (Clone 165903, R&D Systems), FITC Mouse IgG1 κ Isotype Control (Clone MOPC-21 ...
-
bioRxiv - Immunology 2022Quote: ... and a human IL-8/CXCL8 ELISA kit (R&D Systems, D8000C) was used.
-
bioRxiv - Immunology 2021Quote: ... and goat anti-human IFNL (1:25, R&D Systems, Catalog AF1587) antibodies ...
-
bioRxiv - Developmental Biology 2019Quote: ... NIBR0213 (Novartis) and recombinant carrier-free human VEGF-A165 (R&D systems).
-
bioRxiv - Cell Biology 2019Quote: ... and 10ng/ml TGF-β3 (recombinant human, R&D Systems, Minneapolis, MA). On day 21 ...
-
bioRxiv - Pathology 2019Quote: ... Recombinant Human IL-34 (100ng/mL, R&D systems 5265-IL-010), CSF-1 Recombinant Human Protein (25ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... with the following antibodies: goat-anti-human IL13Rα2 (R&D systems, polyclonal), mouse-anti-human EGFR (Dako ...
-
bioRxiv - Genomics 2020Quote: ... and 50 ng/ml human FGF10 (R&D Systems 338-FG-025). After 48 hr ...
-
bioRxiv - Immunology 2021Quote: The Proteome Profiler Human Cytokine Array Kit (R&D Systems, Minnesota, USA) was employed to determine the relative levels of 36 different cytokines and the assay was performed according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2021Quote: ... and human TRAIL R4/TNFRSF 10D PE- conjugated antibody (R&D Systems). In addition ...